Serum 4β-hydroxycholesterol increases during fluconazole treatment

PURPOSE: The antifungal drugs ketoconazole and itraconazole reduce serum concentrations of 4β-hydroxycholesterol, which is a validated marker for hepatic cytochrome P450 (CYP) 3A4 activity. We tested the effect of another antifungal triazole agent, fluconazole, on serum concentrations of different s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lütjohann, Dieter, Stellaard, Frans, Kerksiek, Anja, Lötsch, Jörn, Oertel, Bruno G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032583/
https://www.ncbi.nlm.nih.gov/pubmed/33201347
http://dx.doi.org/10.1007/s00228-020-03041-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032583/
https://www.ncbi.nlm.nih.gov/pubmed/33201347
http://dx.doi.org/10.1007/s00228-020-03041-5

Ejemplares similares